Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells

Cell Biol Int. 2022 Dec;46(12):1999-2008. doi: 10.1002/cbin.11892. Epub 2022 Aug 23.

Abstract

Mesenchymal (human amniotic mesenchymal stem cell [HAMSC]) and epithelial cells (human amnion epithelial cell [HAEC]) derived from human amniotic membranes possess characteristics of pluripotency. However, the pluripotency of HAMSC and HAEC are sustained only for a finite period. This in vitro cell growth can be extended by cell immortalisation. Many well-defined immortalisation systems have been used for artificially overexpressing genes such as human telomerase reverse transcriptase in HAMSC and HAEC leading to controlled and prolonged cell proliferation. In recent years, much progress has been made in our understanding of the cellular machinery that regulates the cell cycle when immortalised. This review summarises the current understanding of molecular mechanisms that contribute to cell immortalisation, the strategies that have been employed to immortalise amnion-derived cell types, and their likely applications in regenerative medicine.

Keywords: amnion epithelial cells; hTERT; immortalisation; mesenchymal cells; placenta.

Publication types

  • Review

MeSH terms

  • Amnion*
  • Cell Differentiation / physiology
  • Cell Proliferation
  • Epithelial Cells
  • Humans
  • Mesenchymal Stem Cells*
  • Regenerative Medicine